NCT03123211 2022-05-24
Expanded Access to Veliparib
AbbVie
No longer available
Clinical Trials
4 trialsNCT04320693 2021-08-19
Expanded Access for IMMU-132
Gilead Sciences
Approved for marketing
NCT02985658 2021-07-21
Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
University of Washington
No longer available
NCT01130259 2013-09-17
An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
Sanofi
No longer available